A scientific panel is recommending that people 50 and older get a shot against bacteria that can cause pneumonia and other ...
"A lot of the efforts that we're doing across the government have a plug into the artificial intelligence world," said Andy Kilianski.
ACIP also unanimously voted to include high-dose and adjuvanted inactivated influenza vaccines as options for solid organ ...
With an expanded recommendation from the Center for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization ...
Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...
The Food and Drug Administration (FDA) has approved Abrysvo ® (respiratory syncytial virus [RSV] vaccine) for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by ...
Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.
The FDA expanded the approval of the bivalent RSV prefusion F (RSVpreF) vaccine (Abrysvo) to include the prevention of lower ...
The US Food and Drug Administration (FDA) has expanded the indication for Pfizer’s respiratory syncytial virus (RSV) vaccine ...
Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...
The campaign “caused Americans to lose trust in the public health system,” House Energy and Commerce Committee Chair Cathy ...